Biotech Values

[dewophile]

in the hospital setting i don't think pricing affects demand much if at all - especially once you factor in savings from eliminating need for monitoring anticoagulation

on an outpt basis i'm sure the copays and/or out of pocket differential between lovenox and UH will enable some conversion of UH to lovenox

just a guess